三友医疗: 2025年限制性股票激励计划（草案）摘要公告

Core Viewpoint - Shanghai Sanyou Medical Devices Co., Ltd. has announced a stock incentive plan to grant 4.782 million restricted stocks, accounting for 1.43% of the company's total share capital, aimed at attracting and retaining talent while aligning the interests of shareholders, the company, and core team members [1][3][4]. Group 1: Incentive Plan Overview - The incentive plan involves granting restricted stocks as a means of employee motivation [3][4]. - The total number of restricted stocks to be granted is 4.782 million, which is approximately 1.43% of the company's total share capital of 333.462498 million shares [1][4]. - The stocks will be sourced from shares repurchased from the secondary market or newly issued shares directed to the incentive recipients [3][4]. Group 2: Eligibility and Distribution - The incentive recipients include 55 individuals, primarily directors, senior management, and key personnel, excluding independent directors [5][6]. - The distribution of restricted stocks among recipients is structured, with specific allocations for directors and senior management [5][6]. Group 3: Granting and Vesting Conditions - The grant price for the restricted stocks is set at 11.12 yuan per share, which is based on a formula ensuring it is not lower than the stock's par value or a percentage of the average trading price prior to the announcement [10][11]. - The vesting of the stocks is contingent upon meeting performance targets related to revenue growth, with specific thresholds set for the years 2025 and 2026 [14][16]. Group 4: Performance Assessment - The performance assessment will be conducted annually, with the first assessment in 2025 and the second in 2026, based on the company's revenue growth rate [14][16]. - The plan includes a dual-layer assessment: company-level performance and individual performance, which will determine the actual number of stocks vested to each recipient [16][17]. Group 5: Legal and Procedural Framework - The plan adheres to relevant laws and regulations, including the Company Law and Securities Law, and requires approval from the board and shareholders [2][3][5]. - The implementation of the plan involves a series of procedural steps, including public disclosure and legal opinions from independent advisors [18][19].